AI Portfolio Summary
In 2025 Q4, Ishara Investments LP maintained a portfolio of 38 distinct positions. The most significant new addition to the portfolio was PRAXIS PRECISION MED, which now represents 13.48% of the total fund value.
Total Positions
38
Quarter
2025 Q4
Top Holding
PRAX (13.5%)
Top 10 Concentration
55.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-38 of 38
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 13.48% | — |
#1
Prev: #—
|
9.5 | 40,000 | no change |
NEW
|
40,000 | $11,789,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 7.18% | — |
#2
Prev: #—
|
7.9 | 800,000 | no change |
NEW
|
800,000 | $6,280,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 6.80% | — |
#3
Prev: #—
|
7.2 | 100,000 | no change |
NEW
|
100,000 | $5,943,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 5.86% | — |
#4
Prev: #—
|
6.3 | 360,000 | no change |
NEW
|
360,000 | $5,126,400 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 4.89% | — |
#5
Prev: #—
|
6.0 | 160,000 | no change |
NEW
|
160,000 | $4,273,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANNX
ANNEXON INC
|
Healthcare | 4.31% | — |
#6
Prev: #—
|
5.2 | 750,000 | no change |
NEW
|
750,000 | $3,765,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 4.10% | — |
#7
Prev: #—
|
5.1 | 400,000 | no change |
NEW
|
400,000 | $3,584,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 3.15% | — |
#8
Prev: #—
|
4.8 | 36,000 | no change |
NEW
|
36,000 | $2,753,640 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 3.13% | — |
#9
Prev: #—
|
4.8 | 36,000 | no change |
NEW
|
36,000 | $2,734,560 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.06% | — |
#10
Prev: #—
|
4.7 | 5,500 | no change |
NEW
|
5,500 | $2,679,875 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 2.68% | — |
#11
Prev: #—
|
4.6 | 300,000 | no change |
NEW
|
300,000 | $2,340,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.64% | — |
#12
Prev: #—
|
4.6 | 50,000 | no change |
NEW
|
50,000 | $2,307,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GMAB
GENMAB A/S
|
Healthcare | 2.47% | — |
#13
Prev: #—
|
4.5 | 70,000 | no change |
NEW
|
70,000 | $2,156,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.40% | — |
#14
Prev: #—
|
4.5 | 100,000 | no change |
NEW
|
100,000 | $2,101,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VSTM
VERASTEM INC
|
Healthcare | 2.38% | — |
#15
Prev: #—
|
4.5 | 270,000 | no change |
NEW
|
270,000 | $2,084,400 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 2.25% | — |
#16
Prev: #—
|
4.4 | 24,000 | no change |
NEW
|
24,000 | $1,965,120 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APOG
APOGEE ENTERPRI...
|
Industrials | 2.16% | — |
#17
Prev: #—
|
4.4 | 25,000 | no change |
NEW
|
25,000 | $1,887,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 2.04% | — |
#18
Prev: #—
|
4.3 | 1,320,000 | no change |
NEW
|
1,320,000 | $1,782,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 1.99% | — |
#19
Prev: #—
|
4.3 | 10,000 | no change |
NEW
|
10,000 | $1,740,400 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CORT
CALL
CORCEPT THERAPE...
|
CALL Option | 1.75% | — |
#20
Prev: #—
|
4.2 | 44,000 | no change |
NEW
|
44,000 | $1,531,200 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.67% | — |
#21
Prev: #—
|
4.2 | 240,000 | no change |
NEW
|
240,000 | $1,459,200 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.65% | — |
#22
Prev: #—
|
4.2 | 58,000 | no change |
NEW
|
58,000 | $1,439,270 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 1.58% | — |
#23
Prev: #—
|
4.1 | 50,000 | no change |
NEW
|
50,000 | $1,386,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.50% | — |
#24
Prev: #—
|
4.1 | 160,000 | no change |
NEW
|
160,000 | $1,308,800 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.44% | — |
#25
Prev: #—
|
4.1 | 50,000 | no change |
NEW
|
50,000 | $1,256,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.32% | — |
#26
Prev: #—
|
4.0 | 70,000 | no change |
NEW
|
70,000 | $1,155,700 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.31% | — |
#27
Prev: #—
|
4.0 | 50,000 | no change |
NEW
|
50,000 | $1,150,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.22% | — |
#28
Prev: #—
|
4.0 | 5,000 | no change |
NEW
|
5,000 | $1,066,200 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 1.20% | — |
#29
Prev: #—
|
4.0 | 30,000 | no change |
NEW
|
30,000 | $1,052,400 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LXRX
LEXICON PHARMAC...
|
Healthcare | 1.16% | — |
#30
Prev: #—
|
4.0 | 880,000 | no change |
NEW
|
880,000 | $1,012,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 1.14% | — |
#31
Prev: #—
|
4.0 | 88,000 | no change |
NEW
|
88,000 | $993,520 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.13% | — |
#32
Prev: #—
|
4.0 | 24,000 | no change |
NEW
|
24,000 | $989,040 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.97% | — |
#33
Prev: #—
|
3.9 | 20,000 | no change |
NEW
|
20,000 | $845,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 0.96% | — |
#34
Prev: #—
|
3.9 | 80,000 | no change |
NEW
|
80,000 | $840,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.93% | — |
#35
Prev: #—
|
3.9 | 30,000 | no change |
NEW
|
30,000 | $816,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.87% | — |
#36
Prev: #—
|
3.8 | 30,000 | no change |
NEW
|
30,000 | $762,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.86% | — |
#37
Prev: #—
|
3.8 | 30,000 | no change |
NEW
|
30,000 | $750,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.40% | — |
#38
Prev: #—
|
3.7 | 12,000 | no change |
NEW
|
12,000 | $348,480 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-38 of 38 holdings